Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michail Doukas

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Journal of Crohn'S & Colitis|September 12, 2022
Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk StratificationJeanine H C Arkenbosch, Evelien M J Beelen, Gerard Dijkstra, et al.
Nature|July 1, 2026
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRCYiming Peng-Winkler, Xiao-Zheng Liu, Sanne M L Verheul, et al.
Trials|May 18, 2021
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancerBen M Eyck, Berend J van der Wilk, Bo Jan Noordman, et al.
Annals of Surgery|May 7, 2025
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn's Disease after Ileocolic Resection: Results from A Prospective Multicenter Cohort StudyMichiel T J Bak, Lindsey Oudijk, Ariadne H A G Ooms, et al.
Hepatology (Baltimore, Md.)|June 13, 2025
Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancementGuido Carpino, Diletta Overi, Rocio Ir Macias, et al.
Annals of Surgery|May 6, 2024
Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic CancerThijs J Schouten, Victor J Kroon, Marc G Besselink, et al.
British Journal of Cancer|June 1, 2022
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insightsEmily Latacz, Diederik Höppener, Ali Bohlok, et al.
The Lancet. Oncology|March 20, 2025
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, et al.
The British Journal of Surgery|November 28, 2025
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysisJulia E Menso, Caro L Bruna, Mahsoem Ali, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|June 22, 2026
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic cholangiocarcinoma: Pooled individual patient-level analysis of four clinical trialsMerve Rousian, Remo Alessandris, Lauren Schleimer, et al.
Journal of Crohn'S & Colitis|September 12, 2022
Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk StratificationJeanine H C Arkenbosch, Evelien M J Beelen, Gerard Dijkstra, et al.
Nature|July 1, 2026
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRCYiming Peng-Winkler, Xiao-Zheng Liu, Sanne M L Verheul, et al.
Trials|May 18, 2021
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancerBen M Eyck, Berend J van der Wilk, Bo Jan Noordman, et al.
Annals of Surgery|May 7, 2025
Combined Clinical and Histopathological Risk Stratification for Prediction of (severe) Endoscopic Postoperative Recurrence in Patients with Crohn's Disease after Ileocolic Resection: Results from A Prospective Multicenter Cohort StudyMichiel T J Bak, Lindsey Oudijk, Ariadne H A G Ooms, et al.
Hepatology (Baltimore, Md.)|June 13, 2025
Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancementGuido Carpino, Diletta Overi, Rocio Ir Macias, et al.
Annals of Surgery|May 6, 2024
Perineural Invasion is an Important Prognostic Factor in Patients With Radically Resected (R0) and Node-negative (pN0) Pancreatic CancerThijs J Schouten, Victor J Kroon, Marc G Besselink, et al.
British Journal of Cancer|June 1, 2022
Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insightsEmily Latacz, Diederik Höppener, Ali Bohlok, et al.
The Lancet. Oncology|March 20, 2025
Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trialBerend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, et al.
The British Journal of Surgery|November 28, 2025
Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysisJulia E Menso, Caro L Bruna, Mahsoem Ali, et al.
Pageof 13